Case Study: Regenerative medicine sponsor streamlines Phase IV study workflows with Clinion’s unified eConsent, EDC, ePRO, and eTMF platform

A Clinion Case Study

Preview of the Regenerative Medicine Sponsor Case Study

Regenerative Medicine Sponsor streamlines a 200-participant Phase IV study with Clinion

A regenerative medicine sponsor faced challenges managing a Phase IV study, needing to connect participant consent, clinical follow-up data, quality-of-life responses, and trial documentation across 200 participants and a 96-page eCRF. They engaged Clinion to implement an integrated platform combining eConsent, EDC, ePRO, and eTMF to streamline these fragmented workflows.

Clinion deployed a unified environment where eConsent automatically enrolled subjects into EDC, ePRO directly captured patient-reported outcomes, and eTMF provided live tracking of document completeness. This solution reduced manual handoffs, ensured cleaner data flow, and strengthened inspection readiness throughout the study. Clinion helped the sponsor achieve a more efficient and controlled long-term follow-up study.


View this case study…

Clinion

3 Case Studies